2019 Novel Coronavirus Is Undergoing Active Recombination
Huiguang Yi
Clinical Infectious Diseases, doi:10.1093/cid/ciaa219
www. maths.otago.ac.nz/~dbryant/software/phimanual. pdf 9. Jiang X, Robertson DL. nCoV's relationship to bat coronaviruses and recombination signals (no snakes)-no evidence the 2019-nCoV lineage is recombinant. 2020.
References
Barnard, Day, Bailey, Evaluation of immunomodulators, interferons and known in vitro SARS-coV inhibitors for inhibition of SARS-coV replication in BALB/c mice, Antivir Chem Chemother
De Wilde, Jochmans, Posthuma, Screening of an FDA-approved compound library identifies four small-molecule inhibitors of Middle East respiratory syndrome coronavirus replication in cell culture, Antimicrob Agents Chemother
Savarino, Boelaert, Cassone, Majori, Cauda, Effects of chloroquine on viral infections: an old drug against today's diseases?, Lancet Infect Dis
Savarino, Boelaert, Cassone, Majori, Cauda, Effects of chloroquine on viral infections: an old drug against today's diseases?, Lancet Infect Dis
Schwartz, King, Protecting health care workers during the COVID-19 coronavirus outbreak: lessons from Taiwan's SARS response
Yao, Ye, Zhang, In vitro antiviral activity and projection of optimized dosing design of hydroxychloroquine for the treatment of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
Yao, Ye, Zhang, In vitro antiviral activity and projection of optimized dosing design of hydroxychloroquine for the treatment of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), Clin Infect Dis
{ 'indexed': {'date-parts': [[2024, 2, 27]], 'date-time': '2024-02-27T14:23:16Z', 'timestamp': 1709043796329},
'reference-count': 6,
'publisher': 'Oxford University Press (OUP)',
'issue': '15',
'license': [ { 'start': { 'date-parts': [[2020, 3, 24]],
'date-time': '2020-03-24T00:00:00Z',
'timestamp': 1585008000000},
'content-version': 'vor',
'delay-in-days': 0,
'URL': 'https://academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model'}],
'content-domain': {'domain': [], 'crossmark-restriction': False},
'published-print': {'date-parts': [[2020, 7, 28]]},
'DOI': '10.1093/cid/ciaa320',
'type': 'journal-article',
'created': {'date-parts': [[2020, 3, 21]], 'date-time': '2020-03-21T12:10:12Z', 'timestamp': 1584792612000},
'page': '887-888',
'source': 'Crossref',
'is-referenced-by-count': 16,
'title': 'Is Hydroxychloroquine a Possible Postexposure Prophylaxis Drug to Limit the Transmission to '
'Healthcare Workers Exposed to Coronavirus Disease 2019?',
'prefix': '10.1093',
'volume': '71',
'author': [ { 'given': 'Pasquale',
'family': 'Pagliano',
'sequence': 'first',
'affiliation': [ { 'name': 'Department of Medicine and Surgery, University of Salerno, '
'Baronissi, Italy'}]},
{ 'given': 'Ornella',
'family': 'Piazza',
'sequence': 'additional',
'affiliation': [ { 'name': 'Department of Medicine and Surgery, University of Salerno, '
'Baronissi, Italy'}]},
{ 'given': 'Francesco',
'family': 'De Caro',
'sequence': 'additional',
'affiliation': [ { 'name': 'Department of Medicine and Surgery, University of Salerno, '
'Baronissi, Italy'}]},
{ 'given': 'Tiziana',
'family': 'Ascione',
'sequence': 'additional',
'affiliation': [ { 'name': 'Service of Infectious Diseases, Cardarelli Hospital, Naples, '
'Italy'}]},
{ 'given': 'Amelia',
'family': 'Filippelli',
'sequence': 'additional',
'affiliation': [ { 'name': 'Department of Medicine and Surgery, University of Salerno, '
'Baronissi, Italy'}]}],
'member': '286',
'published-online': {'date-parts': [[2020, 3, 24]]},
'reference': [ { 'key': '2020072806270834900_CIT0001',
'doi-asserted-by': 'crossref',
'first-page': '732',
'DOI': '10.1093/cid/ciaa237',
'article-title': 'In vitro antiviral activity and projection of optimized dosing design '
'of hydroxychloroquine for the treatment of severe acute respiratory '
'syndrome coronavirus 2 (SARS-CoV-2) [manuscript published online ahead '
'of print 9 March 2020]',
'volume': '71',
'author': 'Yao',
'year': '2020',
'journal-title': 'Clin Infect Dis'},
{ 'key': '2020072806270834900_CIT0002',
'doi-asserted-by': 'crossref',
'first-page': '858',
'DOI': '10.1093/cid/ciaa255',
'article-title': 'Protecting health care workers during the COVID-19 coronavirus '
'outbreak: lessons from Taiwan’s SARS response [manuscript published '
'online ahead of print 12 March 2020]',
'volume': '71',
'author': 'Schwartz',
'year': '2020',
'journal-title': 'Clin Infect Dis'},
{ 'key': '2020072806270834900_CIT0003',
'doi-asserted-by': 'crossref',
'first-page': '722',
'DOI': '10.1016/S1473-3099(03)00806-5',
'article-title': 'Effects of chloroquine on viral infections: an old drug against today’s '
'diseases?',
'volume': '3',
'author': 'Savarino',
'year': '2003',
'journal-title': 'Lancet Infect Dis'},
{ 'key': '2020072806270834900_CIT0004',
'doi-asserted-by': 'crossref',
'first-page': '15771',
'DOI': '10.1038/s41598-017-15467-6',
'article-title': 'Repurposing of the anti-malaria drug chloroquine for Zika virus '
'treatment and prophylaxis',
'volume': '7',
'author': 'Shiryaev',
'year': '2017',
'journal-title': 'Sci Rep'},
{ 'key': '2020072806270834900_CIT0005',
'doi-asserted-by': 'crossref',
'first-page': '69',
'DOI': '10.1186/1743-422X-2-69',
'article-title': 'Chloroquine is a potent inhibitor of SARS coronavirus infection and '
'spread',
'volume': '2',
'author': 'Vincent',
'year': '2005',
'journal-title': 'Virol J'},
{ 'key': '2020072806270834900_CIT0006',
'article-title': 'Clinical trial analysis of 2019-nCoV therapy registered in China '
'[manuscript published online ahead of print 28 February 2020]',
'author': 'Zhang',
'year': '2020',
'journal-title': 'J Med Virol'}],
'container-title': 'Clinical Infectious Diseases',
'original-title': [],
'language': 'en',
'link': [ { 'URL': 'http://academic.oup.com/cid/advance-article-pdf/doi/10.1093/cid/ciaa320/33040019/ciaa320.pdf',
'content-type': 'application/pdf',
'content-version': 'am',
'intended-application': 'syndication'},
{ 'URL': 'http://academic.oup.com/cid/article-pdf/71/15/887/33538075/ciaa320.pdf',
'content-type': 'application/pdf',
'content-version': 'vor',
'intended-application': 'syndication'},
{ 'URL': 'http://academic.oup.com/cid/article-pdf/71/15/887/33538075/ciaa320.pdf',
'content-type': 'unspecified',
'content-version': 'vor',
'intended-application': 'similarity-checking'}],
'deposited': { 'date-parts': [[2021, 3, 5]],
'date-time': '2021-03-05T13:05:03Z',
'timestamp': 1614949503000},
'score': 1,
'resource': {'primary': {'URL': 'https://academic.oup.com/cid/article/71/15/887/5811417'}},
'subtitle': [],
'short-title': [],
'issued': {'date-parts': [[2020, 3, 24]]},
'references-count': 6,
'journal-issue': { 'issue': '15',
'published-online': {'date-parts': [[2020, 3, 24]]},
'published-print': {'date-parts': [[2020, 7, 28]]}},
'URL': 'http://dx.doi.org/10.1093/cid/ciaa320',
'relation': {},
'ISSN': ['1058-4838', '1537-6591'],
'subject': [],
'published-other': {'date-parts': [[2020, 8, 1]]},
'published': {'date-parts': [[2020, 3, 24]]}}